Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS3358690 A
Publication typeGrant
Publication dateDec 19, 1967
Filing dateNov 18, 1964
Priority dateNov 18, 1964
Publication numberUS 3358690 A, US 3358690A, US-A-3358690, US3358690 A, US3358690A
InventorsCohen Marvin M
Original AssigneeCohen Marvin M
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Heart stimulator utilizing a pressuresensitive semiconductor
US 3358690 A
Images(1)
Previous page
Next page
Description  (OCR text may contain errors)

Dec. 19, 1967 M M. COHEN HEART STII-ZULATOR UTILIZING A PRESSURE-SENSITIVE SEMICONDUCTOR Filed Nov. 18, 1964 AORTA E- 1%? RT. AURIGLE V 7 Zia; 2: l3 1/ LEFT AURICLE 3 PRESSURE l4- TRANSDUCER ,DELAY [-5 CIRCUIT TRICUSPID j.- VALVE -swncnms j: i I I RT. VENTRICLE 1. 1 L5 'I 3 LEFT vENTRlcLE- ELECTRODE '1'. l9

07c. POWER '7 SOURCE 5 I6 I6 I i I I I 0.0. POWER PRESSURE DELAY SWITCHING fi SOURCE TRANSDUCER CIRCUIT CIRCUIT SOURCE l/VVE/VTOR MARVIN M. COHEN B) W I 6-! J: 9, ATTORNEYJ.

United States Patent 3,358,690 HEART STIMULATOR UTILIZING A PRESSURE- SENSITIVE SEMICONDUCTOR Marvin M. Cohen, Silver Spring, Md., assignor to United States of America as represented by the Secretary of the Army Filed Nov. 18, 1964, Ser. No. 412,268 3 Claims. (Cl. 128-419) ABSTRACT OF THE DISCLOSURE A heart stimulator in which a pressure-sensitive transducer,-such as a tunnel diode -is placed within the walls of an auricle in the heart. When a high pressure condition is reached, a switching signal is transmitted to a switching circuit, after being delayed, and a DC power source is activated thereby activating an electrode placed in the ventricle.

This invention relates to a heart stimulator. More particularly, this invention relates to an ingenious electronic system for stimulating the heart in order to effect pumping of blood in tune to the need put on the circulatory system.

Of fairly recent vintage are electronic systems for heart stimulation, known as Pacemakers. The known Pacemakers work in an ingenious manner to stimulate the ventricle, either the right or left ventricle, or both, in order to provide necessary stimuli in the event that heart blockage has atrophied normal nerve ends in the muscle walls of the heart.

It is well known that nodes of nerve endings are situated on the atrium portion of the heart, being located on the right auricle and left auricle. In effect, these nodes act as pressure transducers, continuously telemetering pressure changes in the auricles so that as the pressure increases, the tricuspid valve between the right auricle and right ventricle, and the mitral valve between the left auricle and left ventricle, are opened and the appropriate ventricles suck in the blood from their respective auricles and pulse out the blood through their respective pulmonary artery and aorta. In other words, as pressure is built up in the atrium, nerve endings and nerve networks in the wall of the heart lead to suitable nodes in the ventricle portion of the heart to dispose of the blood in suitable pressurized fashion. Even though the heart reacts to the pressure change as telemetered from the atrium to the ventricle, the ventricle itself has a natural beat.

Some congenital heart defects are of a type resulting in what is known as a blockage. In such instances the naturally performing telemetering operation mentioned in the preceding paragraph is in malfunction so that the heart operates inefiiciently. The newly developed Pacemakers take over the telemetering function to an extent by provid ing the ventricle with suitably spaced pulses of electrical energy as if, in fact, the nerve networks of the heart were delivering such pulses. Unfortunately, the prior art Pacemakers leave much to be desired inasmuch as they produce a constant pulse frequency, not variable to the requirements of the individual. In other Words, the Pacemaker, in delivering its electrical pulses does so at a beat ordinarily prevalent when the individual is at repose. In the event the individual is engaged in strenuous activity requiring a greater quantity of blood, the Pacemaker does not operate on a faster rate, but actually fights the individual in his additional requirements for blood flow. On the other hand, when the individual is asleep, the Pacemaker does not decrease its frequency, but maintains a constant rate, thereby producing a greater flow of blood than is necessary and oftentimes prevents the individual from obtaining restful sleep.

Accordingly, the primary object of the present invention I 3,358,690 Patented Dec. 19, 1967 is to provide a unique telemetering system resulting in heart stimulation accounting for variances in the need for blood supply.

It is another object of the present invention to disclose an electrical system utilizable in a heart stimulation program.

It is yet another object of the present invention to proide a heart stimulator which is extremely compact and is efficient in operation.

Additional objects and advantages of the present invention will become apparent upon a more detailed consideration as set forth below and taken in conjunction with the drawings, wherein:. 7

FIGURE 1 is a diagrammatic cross-section of the heart in the diastole phase; and,

FIGURE 2 is a block diagram of the circuitry involved in carrying out the present invention.

Now, turning our attention to FIGURE 1, it will be noted that the cross-sectional view represents a diagrammatical view of a mammalian heart, and in particular the heart of a human being. It will be assumed that the heart will have undergone a degree of heart blockage, which necessitates the implantation of the present invention. Within the walls of the right auricle and/ or the left auricle, a tiny transducer 11 is positioned. This tiny transducer is merely a pressure sensitive element, such as a tunnel diode which, under present day technology, may be constructed to assume an extremely tiny dimension. The pressure transducer 11 is positioned in the walls of the heart near the inner periphery by means of open heart surgery, now nicely perfected by our medical scientists. Tiny leads 12 emerge from the heart and are carried outwardly through the parietal pleura of a power source such as a DC. batery 13. The DC battery provides suitable biasing to the tunnel diode pressure transducer when such is utilized.

The pressure transducer selected is such that it may be sensitive to pressure changes of the type found from low pressure to high pressure conditions in the atrium. When a high pressure condition is achieved in the atrium, the pressure transducer senses it and would ordinarily throw a suitable electronic switch immediately. However, by means of lead line 14, the switching is delayed by means of a conventional delay circuit 15 before it is connected to the conventional switching circuit 16 through lead line 17. When the switching circuit is phased to the on side, the power source 18 is put into the line leading to an electrode 19 through leads 20 and 21. The electrode 19 is of the same type as employed in a Pacemaker and is of an extremely small size.

It will be appreciated that as in the same manner or use of a conventional Pacemaker, the electronic circuitry and power source may be positioned outside the body or may be located directly below the skin and outside of the sternum. Such parts of the circuitry would, of course, be the power source 13, the delay circuit 15, the switching circuit 16, and the power source 18.

By positioning the electronic components in this manner and employing tiny leads to the heart, there is practically no discomfort to the individual utilizing this system. The entire arrangement is very small and the power consumption is almost infinitesimal, so that the circuitry of the present system may be removed for the replacement of either the electronic components or the power source, which may be in the form of batteries, by means of a simple operation which may be performed on an annual basis.

In FIGURE 2, a further rendition of the circuitry of the present invention is set forth, showing the DC. battery source 13, the pressure transducer 11, the delay circuit 15, the switching circuitry 16, the DC. power source 18, and the electrode 19. Electrode 19 is positioned in the ventricle portion of the heart, either right or left, or both.

By means of the present invention, it will be seen that technological advances have been made to take the place of damaged heart conditions and that the circuitry involved is, in fact, analogous to the heart circuitry, at least in the function thereby achieved.

It will be apparent that many changes and modifications of the several features described herein may be made without departing from the spirit and scope of the invention. It is, therefore, apparent that the foregoing description is by Way of illustration of the invention rather than limitation of the invention.

What is claimed is:

1. A heart stimulator, comprising:

(a) a pressure sensitive transducer means adapted to be inserted in the atrium of a heart for sensing a high pressure condition in said atrium;

(b) electrode means adapted to be inserted in the ventricle of said heart; and

(c) telemetering means connecting said transducer and said electrode means, said telemetering means comprising a delay circuit, a switching circuit, and a DC power source, said delay circuit being connected to receive the output of said pressure sensitive trans- References Cited UNITED STATES PATENTS 3,184,972 5/ 1965 Sikorski 7 3-698 3,240,207 3/ 1966 Barker 128-205 3,253,596 5/ 1966 Keller 128421 FOREIGN PATENTS 1,067,538 10/ 1959 Germany.

RICHARD A. GAUDET, Primary Examiner.

W. E. KAMM, Assistant Examiner.

Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US3184972 *Apr 24, 1961May 25, 1965Bell Telephone Labor IncPressure transducers
US3240207 *May 31, 1963Mar 15, 1966North American Aviation IncPressure sensor
US3253596 *May 27, 1963May 31, 1966Cordis CorpCardiac pacer
DE1067538B *Mar 29, 1958Oct 22, 1959Siemens Reiniger Werke AgApparat zur Steuerung bzw. Unterstuetzung der Herztaetigkeit durch elektrische Reizstromimpulse
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US3563245 *Mar 15, 1968Feb 16, 1971Mclean Donald NeilBiologically implantable and energized power supply
US3593718 *Jul 13, 1967Jul 20, 1971Biocybernetics IncPhysiologically controlled cardiac pacer
US3638656 *Aug 14, 1969Feb 1, 1972Liechti Ag FredMethod and apparatus for monitoring and stimulating the activity of the heart
US3650277 *Feb 17, 1970Mar 21, 1972Lkb Medical AbApparatus for influencing the systemic blood pressure in a patient by carotid sinus nerve stimulation
US3911897 *Apr 5, 1974Oct 14, 1975Leachman Jr Frank AHeart assist device
US4566456 *Oct 18, 1984Jan 28, 1986Cordis CorporationApparatus and method for adjusting heart/pacer rate relative to right ventricular systolic pressure to obtain a required cardiac output
US4600017 *Jul 19, 1984Jul 15, 1986Cordis CorporationPacing lead with sensor
US4763646 *Dec 9, 1987Aug 16, 1988Siemens AktiengesellschaftHeart pacemaker
US4781715 *Apr 30, 1986Nov 1, 1988Temple University Of The Commonwealth System Of Higher EducationCardiac prosthesis having integral blood pressure sensor
US4791931 *Aug 13, 1987Dec 20, 1988Pacesetter Infusion, Ltd.Demand pacemaker using an artificial baroreceptor reflex
US4791935 *Aug 15, 1986Dec 20, 1988Medtronic, Inc.Implantable lead
US4807629 *Nov 19, 1987Feb 28, 1989Medtronic, Inc.Oxygen sensing pacemaker
US4813421 *Nov 19, 1987Mar 21, 1989Medtronic, Inc.Oxygen sensing pacemaker
US4899751 *Jul 12, 1989Feb 13, 1990Leonard BloomSystem for and method of therapeutic stimulation of a patient's heart
US5058586 *Jul 22, 1988Oct 22, 1991Siemens AktiengesellschaftCatheter for implantation in the heart, having an integrated measuring probe
US5129394 *Jan 7, 1991Jul 14, 1992Medtronic, Inc.Method and apparatus for controlling heart rate in proportion to left ventricular pressure
US5919210 *Apr 10, 1997Jul 6, 1999Pharmatarget, Inc.Device and method for detection and treatment of syncope
US6078834 *Feb 25, 1999Jun 20, 2000Pharmatarget, Inc.Device and method for detection and treatment of syncope
US7136704Apr 16, 2003Nov 14, 2006Alfred E. Mann Foundation For Scientific ResearchBlood oxygen monitoring system and a lead therefor
US7904158Apr 28, 2005Mar 8, 2011Medtronic, Inc.Measurement of coronary sinus parameters to optimize left ventricular performance
DE2112583A1 *Mar 16, 1971Nov 18, 1971Zacouto Fred Dr MedVerfahren zur Feststellung,Steuerung und Beeinflussung des Wertes von Lebensfunktionen,insbesondere des Herzens,bei Menschen und Saeugetieren und Vorrichtung zur Durchfuehrung dieses Verfahrens
DE2613463A1 *Mar 30, 1976Nov 4, 1976Pacer SncHerzschrittmacher
DE3709073A1 *Mar 19, 1987Sep 29, 1988Alt EckhardImplantierbares medizinisches geraet
EP0178528A1 *Oct 1, 1985Apr 23, 1986Telectronics N.V.Method for adjusting heart/pacer rate relative to right ventricular systolic pressure to obtain a required cardiac output
EP0218009A1 *Jun 11, 1986Apr 15, 1987Siemens AktiengesellschaftHeart pace maker
EP0317065A2 *Oct 3, 1988May 24, 1989Todd J. CohenHemodynamically responsive system for treating a malfunctioning heart
WO2006118713A1Mar 28, 2006Nov 9, 2006Medtronic IncMeasurement of coronary sinus parameters to optimize left ventricular performance
Classifications
U.S. Classification607/23, 623/3.28, 600/16
International ClassificationA61B5/0215, A61N1/365
Cooperative ClassificationA61N1/36564, A61B5/0215
European ClassificationA61B5/0215, A61N1/365B9